Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Author response: Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Bradshaw MJ, Gelfand JM, Pawate S.

Neurology. 2018 Jul 3;91(1):51-52. doi: 10.1212/WNL.0000000000005725. No abstract available.

PMID:
29967208
2.

Effectiveness of alternative dose fingolimod for multiple sclerosis.

Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I.

Neurol Clin Pract. 2018 Apr;8(2):102-107. doi: 10.1212/CPJ.0000000000000434.

PMID:
29708225
3.

Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple Sclerosis.

Bagnato F, Hametner S, Franco G, Pawate S, Sriram S, Lassmann H, Gore J, Smith SE, Dortch R.

J Neuroimaging. 2018 Jul;28(4):380-388. doi: 10.1111/jon.12511. Epub 2018 Apr 19.

PMID:
29676026
4.

Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord.

Conrad BN, Barry RL, Rogers BP, Maki S, Mishra A, Thukral S, Sriram S, Bhatia A, Pawate S, Gore JC, Smith SA.

Brain. 2018 Jun 1;141(6):1650-1664. doi: 10.1093/brain/awy083.

PMID:
29648581
5.

Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.

Bagnato F, Hametner S, Boyd E, Endmayr V, Shi Y, Ikonomidou V, Chen G, Pawate S, Lassmann H, Smith S, Welch EB.

PLoS One. 2018 Mar 21;13(3):e0193839. doi: 10.1371/journal.pone.0193839. eCollection 2018.

6.

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S.

Neurology. 2017 Nov 14;89(20):2092-2100. doi: 10.1212/WNL.0000000000004644. Epub 2017 Oct 13.

PMID:
29030454
7.

Quantitative characterization of optic nerve atrophy in patients with multiple sclerosis.

Harrigan RL, Smith AK, Lyttle B, Box B, Landman BA, Bagnato F, Pawate S, Smith SA.

Mult Scler J Exp Transl Clin. 2017 Sep 13;3(3):2055217317730097. doi: 10.1177/2055217317730097. eCollection 2017 Jul-Sep.

8.

Evaluating single-point quantitative magnetization transfer in the cervical spinal cord: Application to multiple sclerosis.

Smith AK, By S, Lyttle BD, Dortch RD, Box BA, Mckeithan LJ, Thukral S, Bagnato F, Pawate S, Smith SA.

Neuroimage Clin. 2017 Jul 14;16:58-65. doi: 10.1016/j.nicl.2017.07.010. eCollection 2017.

9.

Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.

By S, Barry RL, Smith AK, Lyttle BD, Box BA, Bagnato FR, Pawate S, Smith SA.

Magn Reson Med. 2018 Feb;79(2):806-814. doi: 10.1002/mrm.26736. Epub 2017 May 5.

PMID:
28474409
10.

Clinical Reasoning: A 52-year-old man with diplopia and ataxia.

Bradshaw MJ, Pawate S, Bloch KC, Moots P, Reddy NM.

Neurology. 2016 Sep 27;87(13):e140-3. doi: 10.1212/WNL.0000000000003150. No abstract available.

PMID:
27672172
11.

Chemical exchange saturation transfer of the cervical spinal cord at 7 T.

Dula AN, Pawate S, Dethrage LM, Conrad BN, Dewey BE, Barry RL, Smith SA.

NMR Biomed. 2016 Sep;29(9):1249-57. doi: 10.1002/nbm.3581. Epub 2016 Jul 26.

12.

Quantifying the impact of underlying measurement error on cervical spinal cord diffusion tensor imaging at 3T.

By S, Smith AK, Dethrage LM, Lyttle BD, Landman BA, Creasy JL, Pawate S, Smith SA.

J Magn Reson Imaging. 2016 Dec;44(6):1608-1618. doi: 10.1002/jmri.25308. Epub 2016 May 18.

13.

Extended interval dosing of natalizumab in multiple sclerosis.

Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore C, Pandey K, Donnelly S, Pawate S, Bomprezzi R, Smith D, Kolb C, Qureshi S, Okuda D, Kalina J, Rimler Z, Green R, Monson N, Hoyt T, Bradshaw M, Fallon J, Chamot E, Bucello M, Beh S, Cutter G, Major E, Herbert J, Frohman EM.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):885-9. doi: 10.1136/jnnp-2015-312940. Epub 2016 Feb 25.

PMID:
26917698
14.

Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity.

Bradshaw MJ, Pawate S, Lennon VA, Bloch KC, Brown KM.

Neurology. 2015 Dec 15;85(24):2176-7. doi: 10.1212/WNL.0000000000002218. Epub 2015 Nov 13. No abstract available.

15.

Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.

Dula AN, Pawate S, Dortch RD, Barry RL, George-Durrett KM, Lyttle BD, Dethrage LM, Gore JC, Smith SA.

Mult Scler. 2016 Mar;22(3):320-8. doi: 10.1177/1352458515591070. Epub 2015 Jul 24.

16.

7T MRI-Histologic Correlation Study of Low Specific Absorption Rate T2-Weighted GRASE Sequences in the Detection of White Matter Involvement in Multiple Sclerosis.

Bagnato F, Hametner S, Pennell D, Dortch R, Dula AN, Pawate S, Smith SA, Lassmann H, Gore JC, Welch EB.

J Neuroimaging. 2015 May-Jun;25(3):370-8. doi: 10.1111/jon.12238. Epub 2015 Apr 21.

PMID:
25898858
17.

Newer agents in the treatment of multiple sclerosis.

Pawate S, Bagnato F.

Neurologist. 2015 Apr;19(4):104-17. doi: 10.1097/NRL.0000000000000020. Review. Erratum in: Neurologist. 2015 Jul;20(1):22.

PMID:
25888198
18.

Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.

Harrigan RL, Plassard AJ, Bryan FW, Caires G, Mawn LA, Dethrage LM, Pawate S, Galloway RL, Smith SA, Landman BA.

Magn Reson Med. 2016 Jan;75(1):414-22. doi: 10.1002/mrm.25613. Epub 2015 Mar 7.

19.

Extended interval dosing of natalizumab: a two-center, 7-year experience.

Bomprezzi R, Pawate S.

Ther Adv Neurol Disord. 2014 Sep;7(5):227-31. doi: 10.1177/1756285614540224.

20.

Improved diffusion tensor imaging of the optic nerve using multishot two-dimensional navigated acquisitions.

Jeong HK, Dewey BE, Hirtle JA, Lavin P, Sriram S, Pawate S, Gore JC, Anderson AW, Kang H, Smith SA.

Magn Reson Med. 2015 Oct;74(4):953-63. doi: 10.1002/mrm.25469. Epub 2014 Sep 26.

21.

Cranial base manifestations of neurosarcoidosis: a review of 305 patients.

Carlson ML, White JR Jr, Espahbodi M, Haynes DS, Driscoll CL, Aksamit AJ, Pawate S, Lane JI, Link MJ.

Otol Neurotol. 2015 Jan;36(1):156-66. doi: 10.1097/MAO.0000000000000501.

PMID:
25029595
22.

Diagnostic and therapeutic aspects of Hashimoto's encephalopathy.

Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate S.

J Neurol Sci. 2013 Aug 15;331(1-2):67-71. doi: 10.1016/j.jns.2013.05.009. Epub 2013 Jun 5.

PMID:
23759502
23.

Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation.

Kleinfeld K, Mobley B, Hedera P, Wegner A, Sriram S, Pawate S.

J Neurol. 2013 Feb;260(2):558-71. doi: 10.1007/s00415-012-6680-6. Epub 2012 Sep 30. Review.

PMID:
23052599
24.

Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.

Pawate S, Wang L, Song Y, Sriram S.

J Neuroimaging. 2012 Apr;22(2):137-44. doi: 10.1111/j.1552-6569.2011.00622.x. Epub 2011 Jun 24.

PMID:
21707826
25.

Development of chemical exchange saturation transfer at 7 T.

Dula AN, Asche EM, Landman BA, Welch EB, Pawate S, Sriram S, Gore JC, Smith SA.

Magn Reson Med. 2011 Sep;66(3):831-8. doi: 10.1002/mrm.22862. Epub 2011 Mar 22.

26.

The role of infections in the pathogenesis and course of multiple sclerosis.

Pawate S, Sriram S.

Ann Indian Acad Neurol. 2010 Apr;13(2):80-6. doi: 10.4103/0972-2327.64622.

27.

Presentations and outcomes of neurosarcoidosis: a study of 54 cases.

Pawate S, Moses H, Sriram S.

QJM. 2009 Jul;102(7):449-60. doi: 10.1093/qjmed/hcp042. Epub 2009 Apr 20.

PMID:
19383611
28.

The spectrum of Susac's syndrome.

Pawate S, Agarwal A, Moses H, Sriram S.

Neurol Sci. 2009 Feb;30(1):59-64. doi: 10.1007/s10072-008-0004-8. Epub 2009 Jan 15.

PMID:
19145401
29.

Isolated longitudinal myelitis: a report of six cases.

Pawate S, Sriram S.

Spinal Cord. 2009 Mar;47(3):257-61. doi: 10.1038/sc.2008.99. Epub 2008 Aug 19.

PMID:
18711418
30.
31.

Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma.

Pawate S, Shen Q, Fan F, Bhat NR.

J Neurosci Res. 2004 Aug 15;77(4):540-51.

PMID:
15264224
32.

Expression, characterization, and purification of C-terminally hexahistidine-tagged thromboxane A2 receptors.

Pawate S, Schey KL, Meier GP, Ullian ME, Mais DE, Halushka PV.

J Biol Chem. 1998 Aug 28;273(35):22753-60.

Supplemental Content

Loading ...
Support Center